Fibrinolysis in trauma patients: wide variability demonstrated by the Lysis Timer

References

• Davenport R. Pathogenesis of acute traumatic coagulopathy. Transfusion (Paris). 2013;53:23S–27S.
   PubMed Web of Science ®Google Scholar
• Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23–32.
   PubMed Web of Science ®Google Scholar
• Roberts I, Shakur H, Afolabi A, CRASH-2 collaborators, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011;377:1096–1101, 1101.e1–2.
   PubMed Web of Science ®Google Scholar
• Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20:100.
   PubMed Web of Science ®Google Scholar
• Shakur H, Roberts I, Fawole B, et al. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389:2105–2116.
   PubMed Web of Science ®Google Scholar
• Leeper CM, Neal MD, McKenna CJ, et al. Trending fibrinolytic dysregulation: fibrinolysis shutdown in the days after injury is associated with poor outcome in severely injured children. Ann Surg. 2017;266:508–515.
   PubMed Web of Science ®Google Scholar
• Moore HB, Moore EE, Huebner BR, et al. Tranexamic acid is associated with increased mortality in patients with physiological fibrinolysis. J Surg Res. 2017;220:438–443.
   PubMed Web of Science ®Google Scholar
• Gomez-Builes JC, Acuna SA, Nascimento B, et al. Harmful or physiologic: diagnosing fibrinolysis shutdown in a trauma cohort with rotational thromboelastometry. Anesth Analg. 2018;127:840–849.
   PubMed Web of Science ®Google Scholar
• Gall LS, Vulliamy P, Gillespie S, et al. The S100A10 pathway mediates an occult hyperfibrinolytic subtype in trauma patients. Ann Surg. 2018;1. doi: 10.1097/SLA.0000000000002733
   Web of Science ®Google Scholar
• Cardenas JC, Wade CE, Cotton BA, et al. Teg lysis shutdown represents coagulopathy in bleeding trauma patients: analysis of the Proppr cohort. Shock. 2019;51:273–283.
   Web of Science ®Google Scholar
• Johnston LR, Rodriguez CJ, Elster EA, et al. Evaluation of military use of tranexamic acid and associated thromboembolic events. JAMA Surg. 2018;153:169–175.
   PubMed Web of Science ®Google Scholar
• Kowalski E, Kopec M, Niewiarowski S. An evaluation of the euglobulin method for the determination of fibrinolysis. J Clin Pathol. 1959;12:215–218.
   PubMed Web of Science ®Google Scholar
• Fearnley GR, Balmforth G, Fearnley E. Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis. Clin Sci. 1957;16:645–650.
   PubMed Web of Science ®Google Scholar
• Lockhart MS, Lee ET, Taylor FB. Observations on optimal conditions for lysis of whole blood clots and use of this assay as a screening assay in clinical investigation. Thromb Res. 1982;28:625–635.
   PubMed Web of Science ®Google Scholar
• von dem Borne PA, Meijers JC, Bouma BN. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood. 1995;86:3035–3042.
   PubMed Web of Science ®Google Scholar
• Carr ME, Carr SL, McCardell KA. Use of TPA-induced clot lysis time (TCLOT) to diagnose abnormal clot structure and fibrinolysis in a patient with spontaneous bleeding into his leg. Angiology. 1996;47:941–949.
   PubMed Web of Science ®Google Scholar
• He S, Bremme K, Blombäck M. A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary results. Thromb Res. 1999;96:145–156.
   PubMed Web of Science ®Google Scholar
• Kupesiz A, Rajpurkar M, Warrier I, et al. Tissue plasminogen activator induced fibrinolysis: standardization of method using thromboelastography. Blood Coagul Fibrinol. 2010;21:320.
   PubMed Web of Science ®Google Scholar
• Simpson ML, Goldenberg NA, Jacobson LJ, et al. Simultaneous thrombin and plasmin generation capacities in normal and abnormal states of coagulation and fibrinolysis in children and adults. Thromb Res. 2011;127:317–323.
   PubMed Web of Science ®Google Scholar
• Bonnard T, Law LS, Tennant Z, et al. Development and validation of a high throughput whole blood thrombolysis plate assay. Sci Rep. 2017;7:2346.
   PubMed Web of Science ®Google Scholar
• Chapman MP, Moore EE, Moore HB, et al. Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients. J Trauma Acute Care Surg. 2016;80:16–23.
   PubMed Web of Science ®Google Scholar
• Longstaff C. Measuring fibrinolysis: from research to routine diagnostic assays. J Thromb Haemost. 2018;16:652–662.
   PubMed Web of Science ®Google Scholar
• Amiral J, Laroche M, Seghatchian J. A new assay for global fibrinolysis capacity (GFC): investigating a critical system regulating hemostasis and thrombosis and other extravascular functions. Transfus Apher Sci. 2018;57:118–126.
   PubMed Web of Science ®Google Scholar
• Rijken DC, Hoegee-de Nobel E, Jie AFH, et al. Development of a new test for the global fibrinolytic capacity in whole blood. J Thromb Haemost. 2008;6:151–157.
   PubMed Web of Science ®Google Scholar
• Ilich A, Bokarev I, Key NS. Global assays of fibrinolysis. Int J Lab Hem. 2017;39:441–447.
   PubMed Web of Science ®Google Scholar
• Lang T, Bauters A, Braun SL, et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinol. 2005;16:301–310.
   PubMed Web of Science ®Google Scholar
• Peerschke EIB, Castellone DD, Stroobants AK, et al. Reference range determination for whole-blood platelet aggregation using the Multiplate analyzer. Am J Clin Pathol. 2014;142:647–656.
   PubMed Web of Science ®Google Scholar
• Moore HB, Moore EE, Gonzalez E, et al. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg. 2014;77:811–817.
   PubMed Web of Science ®Google Scholar
• Walsh M, Shreve J, Thomas S, et al. Fibrinolysis in trauma: “Myth,” “Reality,” or “Something in Between.”. Semin Thromb Hemost. 2017;43:200–212.
   PubMed Web of Science ®Google Scholar
• Kuiper GJAJM, Kleinegris M-CF, van Oerle R, et al. Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity. Thromb J. 2016;14:1.
   PubMed Web of Science ®Google Scholar
• Levrat A, Gros A, Rugeri L, et al. Evaluation of rotation thromboelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth. 2008;100:792–797.
   PubMed Web of Science ®Google Scholar
• Carroll RC, Craft RM, Langdon RJ, et al. Early evaluation of acute traumatic coagulopathy by thromboelastography. Transl Res. 2009;154:34–39.
   PubMed Web of Science ®Google Scholar
• Tauber H, Innerhofer P, Breitkopf R, et al. Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the “Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study.”. Br J Anaesth. 2011;107:378–387.
   PubMed Web of Science ®Google Scholar
• Raza I, Davenport R, Rourke C, et al. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost. 2013;11:307–314.
   PubMed Web of Science ®Google Scholar
• Gayet-Ageron A, Prieto-Merino D, Ker K, et al. Antifibrinolytic Trials Collaboration. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. Lancet. 2018;391:125–132.
   PubMed Web of Science ®Google Scholar
• Kao C-H, Shu L-C, Yen W-H. Evaluation of a high-speed centrifuge with rapid preparation of plasma for coagulation testing to improve turnaround time. J Biomed Lab Sci. 2010;22:23.
   Google Scholar
• Boissier E, Sévin-Allouet M, Le Thuaut A, et al. A 2-min at 4500 g rather than a 15-min at 2200 g centrifugation does not impact the reliability of 10 critical coagulation assays. Clin Chem Lab Med. 2017;55:e118–e121.
   PubMed Web of Science ®Google Scholar